Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $13.8 million.

  • Champions Oncology's Shares Outstanding (Weighted Average) rose 145.76% to $13.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $13.8 million, marking a year-over-year increase of 145.76%. This contributed to the annual value of $13.7 million for FY2025, which is 82.81% up from last year.
  • According to the latest figures from Q4 2025, Champions Oncology's Shares Outstanding (Weighted Average) is $13.8 million, which was up 145.76% from $13.8 million recorded in Q3 2025.
  • Over the past 5 years, Champions Oncology's Shares Outstanding (Weighted Average) peaked at $13.8 million during Q4 2025, and registered a low of $13.1 million during Q2 2021.
  • In the last 5 years, Champions Oncology's Shares Outstanding (Weighted Average) had a median value of $13.5 million in 2023 and averaged $13.5 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 1377.56% in 2021, then fell by 11.57% in 2023.
  • Over the past 5 years, Champions Oncology's Shares Outstanding (Weighted Average) (Quarter) stood at $13.4 million in 2021, then rose by 0.75% to $13.5 million in 2022, then grew by 0.01% to $13.5 million in 2023, then grew by 0.47% to $13.6 million in 2024, then increased by 1.46% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q4 2025, $13.8 million for Q3 2025, and $13.7 million during Q2 2025.